Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. S-3ASR Offering Registration Statement
  7. 8-K Event Material agreement · Regulation FD disclosure
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 4 Option exercise Chief Operating Officer acquired 27,566 shares (option exercise)
  18. 8-K Event Regulation FD disclosure · Other events
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 5 of 9 · 162 filings